Cipla Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Cipla Quarterly Results    (CIPL)

Here are the latest quarterly results of Cipla. For more details, see the Cipla financial fact sheet and Cipla share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Cipla Quarterly Results

No. of Mths
Qtr. Ending
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m40,07544,04039,89043,95843,71043,76242,76950,383 
Other income Rs m7859547841,005721932655535 
Turnover Rs m40,86144,99340,67444,96344,43144,69443,42350,918 
Expenses Rs m32,99934,42930,84434,86336,12737,42732,97438,617 
Gross profit Rs m7,0779,6119,0469,0957,5836,33510,48811,766 
Depreciation Rs m2,9315,1032,6802,8302,7793,4582,6902,651 
Interest Rs m442448521461462530460393 
Profit before tax Rs m4,4895,0146,6296,8105,0643,2797,9929,257 
Tax Rs m1,2571,2781,9222,0061,5288562,2782,638 
Profit after tax Rs m3,2323,7364,7074,8043,5362,4235,7146,619 
Gross profit margin %17.721.822.720.717.314.524.523.4 
Effective tax rate %28.025.529.029.430.226.128.528.5 
Net profit margin %8.18.511.810.98.15.513.413.1 
Diluted EPS Rs 4.0 4.6 5.8 6.0 4.4 3.0 7.1 8.2  
Diluted EPS (TTM) Rs 16.0 18.7 19.0 20.4 20.8 19.2 20.4 22.7  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Cipla 1QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   SANOFI INDIA  PANACEA BIOTECH  GSK PHARMA  SUVEN LIFESCIENCES  NOVARTIS  

Compare CIPLA With:   SANOFI INDIA  PANACEA BIOTECH  GSK PHARMA  SUVEN LIFESCIENCES  NOVARTIS  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex Jumped 505 Points Today(Closing)

Indian share markets continued momentum and ended their session on a strong note today.

Views on news

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Is this Sector the Best Contrarian Bet Right Now? (Profit Hunter)

Nov 23, 2020

The risk reward ratio in this beaten down sector may have finally turned for the better.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Dec 1, 2020 03:36 PM

TRACK CIPLA

COMPARE CIPLA WITH

MARKET STATS